Email not displaying correctly? View it in your browser
Forward to a colleague | Sign up to BNF eNews
BNF BNF for Children Medicines Complete
September 2016 Share this issue Facebook LinkedIn Twitter
>
I BNF 72 - available this month
>
I Welcome
Welcome to the September BNF eNewsletter.
This month sees the publication of the new BNF 72 and the BNF for Children 2016–17. Read on for more details and pre-order your copies now!

In this eNewsletter you'll also find notifications of new drug monographs for teduglutide and elosulfase alfa. We include a Drug Safety Update on the fire risk associated with paraffin-containing emollients, and new prescribing guidance for biological and biosimilar medicines. We also draw your attention to new guidance for the treatment of short bowel syndrome and anal fissures.
Kind regards,
BNF Team
I In this issue
BNF 72 available to order now More >  
New BNF for Children 2016–2017 More >  
How to purchase BNF More >  
Significant changes More >  
News More >  
Price reminder More >  
Drug safety update More >  
Feedback More >  
BNF BNF 72 available to order now
BNF 72 has been revised and updated to reflect the latest changes in product availability, emerging safety concerns and shifts in clinical practice. In this new edition important safety information is displayed more prominently, drug class monographs are easier to navigate to, and an evidence grade is displayed for new BNF recommendations.

Significant new content updates include:
Updated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancer
New drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetine
New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
Updated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors (bosutinib, imatinib, dasatanib, nilotinib, and ponatinib), and pomalidomide
NICE guidance including the use of vedolizumab for treating moderately to severely active Crohn’s disease
New guidance on suspected or confirmed drug allergy
 
Find out more and order BNF 72 here.
BNF 71

ISBN: 978 0 85711 273 6
Paperback • 1,472pp

BNFC New BNF for Children 2016–2017
The BNF for Children (BNFC) provides essential, practical information to all healthcare professionals involving in the prescribing, dispensing, monitoring and administration of medicines to children.

Significant new content updates include:
Updated guidance on the management of asthma, obesity, coeliac disease and irritable bowel syndrome
New safety information including:
Risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
Risk of osteonecrosis of the external auditory canal with bisphosphonates
Risk of uterine perforation with intra-uterine contraception
Addition of new preparations including Orphacol® (cholic acid) and Intuniv® (guanfacine), and more
Significant dose changes including nystatin, diamorphine hydrochloride, colistimethate sodium, and more
Guidance on suspected or confirmed drug allergies
 
Find out more and order the BNFC here.
BNFC 2016-2017

ISBN: 978 0 85711 247 7
Paperback • 1,032pp

I How to purchase BNF
Purchase Print copies
Purchase print copies
To order the new September 2016 edition, visit the Pharmaceutical Press website.
More
Purchase a print subscription
Purchase a print subscription and save money
A print subscription is the best way to ensure access to the latest copy of BNF as soon as it publishes.
More
BNF online
BNF online
Outside the UK, content is available via a subscription to MedicinesComplete.
Email us
BNF eBook
BNF eBook
>
BNF is also available as a PDF eBook.
More
I Significant
changes
This month's changes to the clinical content of these publications are described in three parts:

BNF & BNFC update should be read by all users of the BNF or BNF for Children
BNF update should be read by all users of the BNF
BNFC update should be read by all users of the BNF for Children
BNF 72 - BNFC 2016-2017
BNF BNF for Children Update
Paraffin-based skin emollients on dressings or clothing: fire risk [MHRA/CHM advice]
In line with a recent MHRA Drug Safety Update, BNF information has been updated to emphasise the risk of fire with any paraffin-based emollient that is covered by a dressing or clothing. For further information, see Emollient and barrier preparations.

You can view the full Drug Safety Update on the MHRA website here.
Biological medicines - new prescribing guidance
For further information, see Guidance on prescribing.
Biosimilar medicines - new prescribing guidance
For further information, see Guidance on prescribing.
Short bowel syndrome - new guidance on management
For further information, see Short bowel syndrome.
Elosulfase alfa: new drug monograph
For further information, see Elosulfase alfa.
Teduglutide: new drug monograph
For further information, see Teduglutide.
BNF Update
Anal fissure - updated guidance on management
For further information, see Anal fissure.
Other changes
To review other changes in BNF, click on changes.
BNF for Children Update
Other changes
To review other changes in BNFC, click on changes.
I News
Did you know?
There's more to the BNF than you may think... See the BNF infographic to find out more about the content and reach of the BNF.
BNF Publications
BNF - help from the CPPE
CPPE have produced a practical guide to using the BNF, which you can access on their website here.
CPPE
I Monthly price update reminder
Prices of all branded medicinal products in the BNF and BNFC are now updated monthly. Prices of generic preparations of medicinal products are updated every 2-4 months, to coincide with print editions of BNF and BNF for Children. The BNF team keep price information up to date using data sourced from the NHS dictionary of medicines and devices (dm+d).
Drug Safety Update
Drug Safety Update is a monthly newsletter from
the MHRA and Commission on Human Medicine.
Please follow this link to review this month's Drug Safety Update.
I Feedback on our eNewsletter
Please let us know if there are any issues that you'd like us to address in our eNewsletters, and if you have any comments on the design. We welcome your feedback. If you have any comments or suggestions, please let us know at marketing@rpharms.com.
Subscribe to this eNewsletter here
I Related Products
Medicines Complete BNF Pharmaceutical Press
BNF
Copyright © 2016 BMJ Publishing Group Ltd and the Royal Pharmaceutical Society of Great Britain. All rights reserved. Terms of use.
BNF for Children
Copyright © 2016 BMJ Publishing Group Ltd, the Royal Pharmaceutical Society of Great Britain and RCPCH Publications. All rights reserved. Terms of use.
If you do not wish to receive such mailings in the future please click here to unsubscribe.
Pharmaceutical Press, 66-68 East Smithfield, London, E1W 1AW, United Kingdom.